News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Carnival announced a $2.5B buyback alongside strong free cash flow, supporting a tactical buy thesis as shares trade near 11x earnings.
  • Amazon reached a tentative deal with USPS to preserve roughly 80% of its current USPS shipments, protecting over one billion annual packages.
  • Nvidia's acquisition of SchedMD raised user concerns that Slurm updates could favor Nvidia hardware, despite commitments to keep it open-source.
  • Amgen's positive Phase 3 TEPEZZA on-body injector data sent Viridian shares sharply lower amid stronger efficacy versus Viridian's subcutaneous results.
  • Atlas Energy announced a $300M convertible note offering, and shares fell 5.6% as proceeds will repay borrowings and fund equipment.
  • AppLovin surged after Wells Fargo raised its price target and revenue forecast based on positive industry checks.
  • Cellebrite pitched as a practical long, citing AI-enabled growth and catalysts with a rebound target despite rich valuation.

Latest Articles

Freight Technologies Announces Strategic Update on Transition to AI-Powered, Software-First Logistics Technology Company

Freight Technologies Announces Strategic Update on Transition to AI-Powered, Software-First Logistics Technology Company

Freight Technologies announced significant progress in transforming into a software-first, AI-native logistics technology company, focusing on scaling its AI-powered platforms like Fleet Rocket, Zayren, and Fr8Radar. The company is exploring strategic alternatives for its traditional brokerage operations to concentrate resources on its AI software …

Scorpio Tankers Inc. Announces Strategic Collaboration with AMPERA, Inc. to Develop & Commercialize Micronuclear Solutions for Global Marine and Shipping Markets

Scorpio Tankers Inc. Announces Strategic Collaboration with AMPERA, Inc. to Develop & Commercialize Micronuclear Solutions for Global Marine and Shipping Markets

Scorpio Tankers Inc. has entered into a strategic collaboration with AMPERA, Inc. to jointly develop and commercialize advanced micronuclear power solutions aimed at powering maritime vessels, offshore, and port infrastructure with zero carbon emissions. The collaboration focuses on deploying ultra-safe micro nuclear reactors, including floating nu…

Burning Rock Announces Founder’s Purchase of Its ADSs

Burning Rock Announces Founder’s Purchase of Its ADSs

Burning Rock Biotech Limited announced that founder, chairman, and CEO Yusheng Han purchased 31,487 American Depositary Shares (ADSs) for $546,603.90 on the open market, adding to prior purchases this year. These transactions signal strong insider confidence in the company's precision oncology business, which focuses on next generation sequencing (…

Acuity Reports Fiscal 2026 Second-Quarter Results

Acuity Reports Fiscal 2026 Second-Quarter Results

Acuity Inc. delivered a robust second-quarter fiscal 2026 performance marked by 5% net sales growth to $1.1 billion, 21% increase in operating profit to $133 million, and a 26% rise in diluted EPS to $3.09. The company's two business segments had mixed results: Acuity Brands Lighting sales slightly declined by 2.8%, while Acuity Intelligent Spaces …

Roivant Announces Expansion of Brepocitinib Development Program with New Phase 2b/3 Trial in Lichen Planopilaris (LPP) and Phase 3 Study Results for Batoclimab in Thyroid Eye Disease (TED)

Roivant Announces Expansion of Brepocitinib Development Program with New Phase 2b/3 Trial in Lichen Planopilaris (LPP) and Phase 3 Study Results for Batoclimab in Thyroid Eye Disease (TED)

Roivant Sciences announced the expansion of its brepocitinib development program to include a new seamless Phase 2b/3 clinical trial for the inflammatory scalp disorder lichen planopilaris (LPP), which currently has no FDA-approved treatments. Concurrently, Roivant reported topline results from Immunovant's Phase 3 studies of batoclimab in thyroid …

Priovant Expands Brepocitinib Development Program with New Phase 2b/3 Trial in Lichen Planopilaris (LPP)

Priovant Expands Brepocitinib Development Program with New Phase 2b/3 Trial in Lichen Planopilaris (LPP)

Priovant Therapeutics announced the initiation of a seamless Phase 2b/3 clinical trial for brepocitinib in treating Lichen Planopilaris (LPP), a severe inflammatory scalp disorder with no FDA-approved treatments. This marks the fourth indication in brepocitinib's late-stage development alongside dermatomyositis, non-infectious uveitis, and cutaneou…

Futu Announces Cash Dividend

Futu Announces Cash Dividend

Futu Holdings Limited, a Nasdaq-listed online brokerage and wealth management platform, declared a cash dividend of $0.325 per ordinary share (equivalent to $2.6 per American Depositary Share), totaling approximately $365 million, payable to shareholders as of April 16, 2026, with payment expected around April 29, 2026.

Seven-Month-Old Killed by Stray Gunfire in Brooklyn; Suspect in Custody

Seven-Month-Old Killed by Stray Gunfire in Brooklyn; Suspect in Custody

A 7-month-old girl riding in a stroller was shot and killed on a Brooklyn street during an apparent gang-related exchange of gunfire. City officials say the child was an unintended target; one suspect has been taken into custody and police continue to seek a second man seen fleeing the scene on a moped.

Administration Plans Steep Tariffs for Drugmakers Lacking U.S. Pricing Deals

Administration Plans Steep Tariffs for Drugmakers Lacking U.S. Pricing Deals

U.S. officials are preparing to announce tariffs on pharmaceutical companies that have not struck deals to guarantee lower prices domestically, with a potential 100% tariff on imported branded and patented medicines. Some multinational drugmakers have negotiated exemptions by committing to pricing arrangements and U.S. investment, while others have…

MediaAlpha Director Sells 12,000 Shares in Three Trades to Cover RSU Taxes

MediaAlpha Director Sells 12,000 Shares in Three Trades to Cover RSU Taxes

MediaAlpha director Steven Yi reported the sale of 12,000 shares of Class A common stock across three trades from March 30 to April 1, 2026, raising $111,907. The transactions, disclosed on a Form 4 filing, were executed under a Rule 10b5-1 trading plan to cover tax liabilities from vested restricted stock units. The company recently posted Q4 2025…